Business
Cochlear posts $238m loss as COVID, patent case bites – Sydney Morning Herald
Underlying profit at the hearing implant maker slid 42 per cent as coronavirus shutdowns impacted sales.
The expense brought the company’s overall net loss to $238.3 million, a 186 per cent drop on last year’s $276.7 million profit.
Cochlear shares rose 6.5 per cent to $211.28 in morning trade.
Chief executive Dig Howitt said the tough coronavirus conditions had not changed the company’s broader goals of retaining and growing market leadership for its products.
He said elective surgeries had started to flow back in key markets but Cochlear was watching closely to evaluate the impact of the pande…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General20 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General13 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General23 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity